Month: June 2019

People’s language could reveal clues about their future risk of developing psychosis. Scientists concluded this after studying the subtle features of people’s everyday speech. Subtle differences in word use can indicate psychosis risk, and machine learning can help identify it. Researchers at Emory University in Atlanta, GA, and Harvard University in Boston, MA, used a
0 Comments
Researchers reveal a marker and new testing tool of frontotemporal dementia that may help distinguish this condition from Alzheimer’s disease. ‘Moral emotions’ are ones that prompt us to do good and contribute to pro-social behavior and cooperation. Frontotemporal dementia (FTD) is a less common form of dementia than Alzheimer’s. Sometimes called Pick’s disease or frontal
0 Comments
Peter Hames Big Health CEO Peter Hames wants people to use his app to treat their insomnia — and then delete it for good. His app, Sleepio, essentially works by leveraging an approach known as cognitive behavioral therapy, which aims to give users the tools to manage their own thought patterns differently and overcome their anxieties.
0 Comments
An inhaler works most effectively when the user manages to deliver their medication in a slow, controlled fashion. Adding a spacer to an inhaler can help a person achieve this goal. Spacers are especially useful for children who may otherwise have difficulty using an inhaler. In this article, we discuss how spacers work, their benefits,
0 Comments
New research in mice uncovers a previously unknown “pathway toward healthy aging.” A circulating protein from the blood of young mice led to health improvements and visible signs of rejuvenation when researchers gave it to aging mice. Scientists have found an enzyme that might have antiaging properties in humans as it does in mice. As
0 Comments
Guanfacine, under the brand name Intuniv, and Adderall are prescription drugs that treat attention deficit hyperactivity disorder. Both drugs help treat the disorder, which people commonly refer to as ADHD, but they work in different ways. In the case of Adderall, it is a stimulant. Conversely, guanfacine is a nonstimulant. In this respect, they are
0 Comments
Nick Leschly, CEO of Bluebird Bio in Cambridge. Wendy Maeda | The Boston Globe | Getty Images Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for
0 Comments
Multiple sclerosis is a progressive disease that can severely damage nerves throughout the body. Symptoms tend to worsen, and as the disease progresses, it can cause impaired speech and motor skills. Multiple sclerosis (MS) can lead to significant difficulties in performing daily tasks and can greatly affect a person’s quality of life. There is no
0 Comments
Older adults with insufficient vitamin K are likely to be at higher risk for mobility disability, according to new research. New research shows that low levels of vitamin K may restrict mobility in older adults. Dietary sources of vitamin K include kale, spinach, broccoli, and other leafy greens. Some dairy foods also contain vitamin K.
0 Comments
Naltrexone, in low doses, has recently become a popular drug for treating multiple sclerosis. This is an off-label use, and research into its effectiveness is still underway. Multiple sclerosis (MS) is a disease that damages the nerve cells. As it progresses, symptoms can get in the way of daily life and impair movement, speech, and
0 Comments
Neurobion is a brand of supplements that contain a combination of B vitamins. Its manufacturers advertise that Neurobion can help improve nerve function. Vitamin B-complex supplements, including Neurobion products, can help treat or prevent certain nutrient deficiencies. Talk to a doctor before taking any supplement, as they can interact with medication. In this article, we
0 Comments
For many years, specialists believed that people who studied more and kept their brains more active had lower dementia risk. Some recent studies have contradicted this idea. So how is education linked to the evolution of Alzheimer’s disease, if at all? Another study suggests that there is no link between a person’s level of education
0 Comments
Bernard Charles, chief executive officer of Dassault Systemes SA. Simon Dawson | Bloomberg | Getty Images French technology company Dassault Systèmes is nearing a deal to acquire Medidata Solutions, according to people familiar with the matter. The likely agreement was reported earlier by Bloomberg, which also published a story in April saying the companies were in
0 Comments
Pooping regularly is a sign of a healthy digestive tract. Everyone’s bowel habits are slightly different, but going too long without pooping can be a sign of an underlying health condition that may require medical attention. There is no specific number of times a person should poop per day, since everyone’s bowel habits are different.
0 Comments
There are two major stumbling blocks to developing effective drugs for Alzheimer’s, Parkinson’s, and other diseases that destroy the brain. The first is overcoming the blood-brain barrier, and the second is delivering the drug to a precise location and ensuring that it does not spread to the rest of the brain. New research finds a
0 Comments